Metastatic Melanoma market, Key Trends, Application Analysis, Regional Outlook & Forecasts to 2016
Global Markets Direct's, 'Metastatic Melanoma - Pipeline Review, H2 2015', provides an overview of the Metastatic Melanoma's therapeutic pipeline.
This report provides comprehensive information on the therapeutic development for Metastatic Melanoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Metastatic Melanoma and special features on late-stage and discontinued projects.
Browse Detail Report With TOC @ http://www.radiantinsights.com/research/metastatic-melanoma-pipeline-review-h2-2015
Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information.
Table Of Content
Table Of Contents 2
List of Tables 8
Buy a Sample copy of This Report @ http://www.radiantinsights.com/checkout/145802
List of Figures 10
Introduction 11
Global Markets Direct Report Coverage 11
Metastatic Melanoma Overview 12
Therapeutics Development 13
Pipeline Products for Metastatic Melanoma - Overview 13
Pipeline Products for Metastatic Melanoma - Comparative Analysis 14
Metastatic Melanoma - Therapeutics under Development by...